Skip to main content

Radiation Therapy for Adrenal Cancer

Radiation therapy uses high-energy x-rays (or particles) to kill cancer cells. Radiation therapy is not used often as the main initial treatment for adrenal cancer because the cancer cells are not easy to kill with x-rays. Radiation may be used after surgery to help keep the tumor from coming back. This is called adjuvant therapy. Radiation can also be used to treat areas of cancer spread, such as in the bones or brain.

Types of radiation therapy

External beam radiation therapy focuses radiation on the cancer from a machine outside the body. Treatments are often given once or twice a day, 5 days a week for several weeks. Treatment is similar to getting an x-ray test, and is not painful. The actual treatment time lasts only a few minutes, although the setup time - getting you into place for treatment - usually takes longer so that the radiation is aimed accurately at the cancer. Before the treatment starts, the radiation team will take careful measurements to find the correct angles for aiming the radiation beams and the proper dose of radiation. This planning session, called simulation, usually includes getting imaging tests such as CT or MRI scans.

Brachytherapy (internal radiation therapy) uses small pellets of radioactive material placed next to or directly into the cancer, sometimes in thin plastic tubes. The tubes containing the pellets are left in place for a few days and then removed. The actual time is determined by the strength of the radioactive pellets and the size of the tumor. This type of radiation is not often used to treat adrenal cortical cancer.

Possible side effects

Common side effects of radiation therapy include:

  • Nausea and vomiting
  • Diarrhea (if an area of the abdomen is treated)
  • Skin changes in the area being treated, which can range from redness to blistering and peeling
  • Hair loss in the area being treated
  • Fatigue
  • Low blood counts

More information about radiation therapy

To learn more about how radiation is used to treat cancer, see Radiation Therapy.

To learn about some of the side effects listed here and how to manage them, see Managing Cancer-related Side Effects.

The American Cancer Society medical and editorial content team

Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

Else T, Williams AR, Sabolch A, et al. Adjuvant therapies, patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma. J Clin Endocrinol Metab. 2013 Dec 3. [Epub ahead of print].

Fassnacht M, Hahner S, Polat B, et al. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. J Clin Endocrinol Metab. 2006;91:4501-4504.

Lam AK. Update on adrenal tumours in 2017 World Health Organization (WHO) of Endocrine Tumours. Endocr Pathol. 2017 Sep;28(3):213-227.

Lirov R, Tobias E, Lerario AM, Hammer GD. Adrenal tumors In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins 2015: Chapter 84.

National Cancer Institute. Physician Data Query (PDQ). Adrenocortical Carcinoma Treatment. 06/02/2015. Accessed at: https://www.cancer.gov/types/adrenocortical/hp/adrenocortical-treatment-pdq  on December 13, 2017.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Neuroendocrine Tumors. v.3.2017. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf on
December 13, 2017.

Rodriguez-Galindo C, Figueiredo BC, Zambetti GP, Ribeiro RC. Biology, clinical characteristics, and management of adrenocortical tumors in children. Pediatr Blood Cancer. 2005;45(3):265-273.

Schneider DF, Mazeh H, Lubner SJ, Jaume JC, Chen H. Cancer of the endocrine system In: Neiderhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, PA. Elsevier: 2014: 1112-1142.

Varghese J, Habra MA. Update on adrenocortical carcinoma management and future directions. Curr Opin Endocrinol Diabetes Obes. 2017 Jun;24(3):208-214.

 

Last Revised: January 2, 2018

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.